Kenneth Grise - Profile and Investment Details

Investor Profile

Kenneth Grise is a Venture Capital, Private Equity Firm, Investor based in Toronto, Ontario, Canada with a diverse investment portfolio that includes companies such as Korro Bio, Inc., GlycoEra AG, BOLD Longevity Growth Fund, T-knife Therapeutics, TransThera | 药捷安康, Strive Health, Alveus Therapeutics Inc, Kinaset Therapeutics, Everside Health, Red Ridge Bio, Parabilis Medicines, Bionaut Labs, knownwell, Turnstone Biologics, RefleXion Medical, Nested Therapeutics, NextPoint Therapeutics, Inc., AAVantgarde, Crossbow Therapeutics, Inc, Seawolf Therapeutics, Inc., . Over time, Kenneth Grise has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Kenneth Grise is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, High-growth Startups, Cybersecurity, Wellness, Digital Infrastructure, Enterprise Software, Fundraising, Investment Management, Strategic Partnerships, Portfolio Management, Medical Technologies, Venture Fundraising, Technology, Software Development, Software, Biotechnology, Medical Devices, Electronic Health Records (EHR), Health and Hospital Services, Clinical Trials, Consumer Software, Digital Health, Developer Tools, Information Technology, B2B, Therapeutics, Health Tech, Internet Infrastructure, Healthcare Technology, Mental Health may find it worthwhile to explore potential connections with Kenneth Grise, as their portfolio suggests a familiarity and interest in this area.

Understanding Kenneth Grise’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.